FDA clears Teva's copy of asthma medicine by AstraZeneca

11/20/2008 | Google

The FDA is allowing Teva Pharmaceutical Industries to market its version of AstraZeneca's Pulmicort Respules, an asthma drug for children. AstraZeneca filed a patent-infringement suit against Teva over the product, and a court hearing is scheduled for Jan. 12.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN